Page last updated: 2024-09-03

omega-n-methylarginine and Lymphoma

omega-n-methylarginine has been researched along with Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, RE; Weigent, DA1
Gal, A; Kennedy, LJ; Tamir, S; Tannenbaum, SR; Wogan, GN1
Heilman, MJ; McDermott, PE; Medot-Pirenne, M; Mills, CD; Saxena, M1

Other Studies

3 other study(ies) available for omega-n-methylarginine and Lymphoma

ArticleYear
The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone.
    Journal of neuroimmunology, 2003, Volume: 134, Issue:1-2

    Topics: Animals; Arginine; Carbocyanines; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance; Growth Hormone; Immune System; Lymphocytes; Lymphoma; Membrane Potentials; Methyl Methanesulfonate; Mice; Mitochondria; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Transport; Receptors, Somatotropin; Stress, Physiological

2003
Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumor.
    Cancer research, 1997, May-15, Volume: 57, Issue:10

    Topics: Animals; Apoptosis; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Female; Immunohistochemistry; Lymph Nodes; Lymphoma; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidation-Reduction; Spleen; Tyrosine

1997
Augmentation of an antitumor CTL response In vivo by inhibition of suppressor macrophage nitric oxide.
    Journal of immunology (Baltimore, Md. : 1950), 1999, Dec-01, Volume: 163, Issue:11

    Topics: Animals; Cytotoxicity, Immunologic; Female; Lymphoma; Macrophage Activation; Macrophages; Mast-Cell Sarcoma; Mice; Neoplasms, Experimental; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; T-Lymphocytes, Cytotoxic; Time Factors; Vaccination

1999